The Market for Brain Death

A silent and deadly epidemic is moving across America. No one is broadcasting it. No one is writing about it. Almost no one is even talking about it. But every day in hospitals, nursing homes and hospices across the country, more and more of our medically vulnerable loved ones are being euthanized.

Indeed, some physicians have admitted to this behavior. A 1998 article from the Journal of the American Medical Association (JAMA) reported that hastening death is occurring and is not rare. In a survey of 355 oncologists, “(15.8%) reported participating in euthanasia or physician assisted suicide,” and “38 of 53 (72%) oncologists described clearly defined cases of euthanasia or physician assisted suicide.¹

These decisions are being made by paid medical professionals. And loved ones, to their horror, are finding they’re not even part of the discussion. The patients’ crimes? They’re charged with having insufficient quality of life, being too expensive to keep alive, and being beyond the reach of medical science and therefore beyond hope.

Such judgments may lie behind what seems to be an increase in the “brain death” diagnosis. The difficulty of making a pinpoint diagnosis in such complex neurological matters—and the lucrative financial incentives to harvest organs—will ultimately propel this issue into the forefront of public consciousness and discourse.

Not surprisingly, the current procurement market for human tissues and organs in the United States is booming, driven by insufficient supply and heavy demand. According to The Milliman Report (see page 4), if all 11 tissues and organs could be harvested from a single patient declared brain-dead, however unlikely, the going rate for procurement would exceed half a million dollars. If all costs related to those 11 transplants are counted—preparation, physicians’ services, post-op care and the like—the money involved exceeds $5.5 million.²

READ MORE: http://www.lifeissues.org/breakingnews/2014/bn9-26-14.htm